A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
- Last Action
- 3/16/2021
Actions
- 2021-03-16Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2021-03-16Introduced in Senate
CRS Summary
As of 2021-03-16 (00)
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
Cosponsors (20)
- Debbie Stabenow (D-MI)
- Rob Portman (R-OH)
- Tammy Baldwin (D-WI)
- Shelley Capito (R-WV)
- Ben Cardin (D-MD)
- Marsha Blackburn (R-TN)
- Kirsten Gillibrand (D-NY)
- Jim Inhofe (R-OK)
- Tina Smith (D-MN)
- Cindy Hyde-Smith (R-MS)
- Sherrod Brown (D-OH)
- John Boozman (R-AR)
- Thomas Carper (D-DE)
- Tom Cotton (R-AR)
- Gary Peters (D-MI)
- Mike Rounds (R-SD)
- Mark Kelly (D-AZ)
- Roger Wicker (R-MS)
- Elizabeth Warren (D-MA)
- Roger Marshall (R-KS)
Subjects
- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Health care coverage and access
- Health facilities and institutions
- Health programs administration and funding
- Home and outpatient care
- Hospital care
- Infectious and parasitic diseases
- Inflation and prices
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.